Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant human growth hormone for short stature in children with achondroplasia
CTR20211788Phase 4Active
- Sponsor
- Anke Bio
- Start
- Feb 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of genotropin miniquick in achondroplasia (ACH), sponsored by Anke Bio. Started Feb 2022; status: active.
02
Drugs
genotropin miniquick
03
Conditions
achondroplasia (ACH)
Beyond the preview
Go deeper on CTR20211788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211788.